Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 2
2016 3
2017 3
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Validation of a Gene Expression Test for Mesothelioma Prognosis in Formalin-Fixed Paraffin-Embedded Tissues.
De Rienzo A, Cook RW, Wilkinson J, Gustafson CE, Amin W, Johnson CE, Oelschlager KM, Maetzold DJ, Stone JF, Feldman MD, Becich MJ, Yeap BY, Richards WG, Bueno R. De Rienzo A, et al. Among authors: oelschlager km. J Mol Diagn. 2017 Jan;19(1):65-71. doi: 10.1016/j.jmoldx.2016.07.011. Epub 2016 Nov 15. J Mol Diagn. 2017. PMID: 27863259 Free PMC article.
A gene signature to determine metastatic behavior in thymomas.
Gökmen-Polar Y, Cook RW, Goswami CP, Wilkinson J, Maetzold D, Stone JF, Oelschlager KM, Vladislav IT, Shirar KL, Kesler KA, Loehrer PJ Sr, Badve S. Gökmen-Polar Y, et al. Among authors: oelschlager km. PLoS One. 2013 Jul 24;8(7):e66047. doi: 10.1371/journal.pone.0066047. Print 2013. PLoS One. 2013. PMID: 23894276 Free PMC article.
Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.
Gerami P, Cook RW, Wilkinson J, Russell MC, Dhillon N, Amaria RN, Gonzalez R, Lyle S, Johnson CE, Oelschlager KM, Jackson GL, Greisinger AJ, Maetzold D, Delman KA, Lawson DH, Stone JF. Gerami P, et al. Among authors: oelschlager km. Clin Cancer Res. 2015 Jan 1;21(1):175-83. doi: 10.1158/1078-0432.CCR-13-3316. Clin Cancer Res. 2015. PMID: 25564571 Free article.
Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy.
Gerami P, Cook RW, Russell MC, Wilkinson J, Amaria RN, Gonzalez R, Lyle S, Jackson GL, Greisinger AJ, Johnson CE, Oelschlager KM, Stone JF, Maetzold DJ, Ferris LK, Wayne JD, Cooper C, Obregon R, Delman KA, Lawson D. Gerami P, et al. Among authors: oelschlager km. J Am Acad Dermatol. 2015 May;72(5):780-5.e3. doi: 10.1016/j.jaad.2015.01.009. Epub 2015 Mar 3. J Am Acad Dermatol. 2015. PMID: 25748297
Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients.
Berger AC, Davidson RS, Poitras JK, Chabra I, Hope R, Brackeen A, Johnson CE, Maetzold DJ, Middlebrook B, Oelschlager KM, Cook RW, Monzon FA, Miller AR. Berger AC, et al. Among authors: oelschlager km. Curr Med Res Opin. 2016 Sep;32(9):1599-604. doi: 10.1080/03007995.2016.1192997. Epub 2016 Jun 3. Curr Med Res Opin. 2016. PMID: 27210115
Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification.
Ferris LK, Farberg AS, Middlebrook B, Johnson CE, Lassen N, Oelschlager KM, Maetzold DJ, Cook RW, Rigel DS, Gerami P. Ferris LK, et al. Among authors: oelschlager km. J Am Acad Dermatol. 2017 May;76(5):818-825.e3. doi: 10.1016/j.jaad.2016.11.051. Epub 2017 Jan 19. J Am Acad Dermatol. 2017. PMID: 28110997 Free article.